Sandusky, Ohio–(Newsfile Corp. – January 14, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today published a management outlook for 2021 on the company’s strategy to develop and monetize the cannabis assets acquired last year. The strategic outlook is included in its entirety below:PAOG 2021 Cannabis Biopharmaceutical Strategic OutlookPAOG is a longtime participant in the cannabis sector working on initiatives to introduce cannabis treatments as alternatives to traditional pharmaceuticals, particularly where existing pharmaceutical …
Source: Kaly
PAOG Publishes 2021 Cannabis Biopharmaceutical Strategic Outlook
Kaly
Related News
-
PAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update Tomorrow
Sandusky, Ohio–(Newsfile Corp. – January 13, 2021) – PAO... -
PAOG Confirms Cannabis Biopharmaceutical Strategic Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021
Sandusky, Ohio–(Newsfile Corp. – January 12, 2021) – PAO... -
Canadian Stocks to Buy: This Cannabis Stock Is Poised to Soar in 2021!
The fact that Curaleaf (TSXV:CURA) is listed on the Canadian...